INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 186 filers reported holding INARI MED INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,208,273 | +550.1% | 308,995 | +477.9% | 0.06% | +530.0% |
| Q2 2023 | $3,108,455 | +123.1% | 53,465 | +136.9% | 0.01% | +100.0% |
| Q1 2023 | $1,393,471 | +62.7% | 22,570 | +67.5% | 0.01% | +66.7% |
| Q4 2022 | $856,661 | +6.4% | 13,478 | +21.6% | 0.00% | -25.0% |
| Q3 2022 | $805,000 | -19.0% | 11,083 | -24.2% | 0.00% | 0.0% |
| Q2 2022 | $994,000 | -92.2% | 14,625 | -89.5% | 0.00% | -90.9% |
| Q1 2022 | $12,663,000 | +20.4% | 139,695 | +21.2% | 0.04% | +29.4% |
| Q4 2021 | $10,521,000 | -25.0% | 115,281 | -33.4% | 0.03% | -30.6% |
| Q3 2021 | $14,030,000 | +54.5% | 172,998 | +77.7% | 0.05% | +53.1% |
| Q2 2021 | $9,082,000 | -0.0% | 97,369 | +14.7% | 0.03% | -20.0% |
| Q1 2021 | $9,084,000 | +48.4% | 84,886 | +21.0% | 0.04% | +48.1% |
| Q4 2020 | $6,121,000 | +229.1% | 70,125 | +160.3% | 0.03% | +285.7% |
| Q3 2020 | $1,860,000 | – | 26,944 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |